Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Wollenberg

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
HNO|March 19, 2021
[Dupilumab has an additional benefit in treatment of chronic rhinosinusitis with nasal polyps]L Klimek, A Chaker, T Deitmer, et al.
Anticancer Research|February 19, 2002
TNFalpha contributes to the antitumor activity of a bispecific, trifunctional antibodyR Zeidler, A Mayer, O Gires, et al.
British Journal of Cancer|July 20, 2000
The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cellsR Zeidler, J Mysliwietz, M Csánady, et al.
HNO|January 23, 2008
[Cell-based strategies for salivary gland regeneration]N Rotter, C Wirz, J Oder, et al.
Scandinavian Journal of Immunology|July 20, 2007
Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognitionP Wrobel, H Shojaei, B Schittek, et al.
HNO|August 4, 2010
[Brachytherapy for the treatment of head and neck cancer]J E Meyer, C Brocks, S Maune, et al.
Nuklearmedizin. Nuclear Medicine|September 12, 2006
High energy probe for detecting lymph node metastases with 18F-FDG in patients with head and neck cancerB Meller, K Sommer, J Gerl, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|September 18, 2013
Assessment of skills using a virtual reality temporal bone surgery simulatorR Linke, A Leichtle, F Sheikh, et al.
Allergy|June 10, 2017
A possible role of stem cells in nasal polyposisL Klimek, M Koennecke, J Mullol, et al.
HNO|July 29, 2005
[Salivary gland carcinomas. 1. Epidemiology, etiology, malignancy criteria, prognostic parameters and classification]S Lang, N Rotter, A Lorenzen, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
HNO|March 19, 2021
[Dupilumab has an additional benefit in treatment of chronic rhinosinusitis with nasal polyps]L Klimek, A Chaker, T Deitmer, et al.
Anticancer Research|February 19, 2002
TNFalpha contributes to the antitumor activity of a bispecific, trifunctional antibodyR Zeidler, A Mayer, O Gires, et al.
British Journal of Cancer|July 20, 2000
The Fc-region of a new class of intact bispecific antibody mediates activation of accessory cells and NK cells and induces direct phagocytosis of tumour cellsR Zeidler, J Mysliwietz, M Csánady, et al.
HNO|January 23, 2008
[Cell-based strategies for salivary gland regeneration]N Rotter, C Wirz, J Oder, et al.
Scandinavian Journal of Immunology|July 20, 2007
Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognitionP Wrobel, H Shojaei, B Schittek, et al.
HNO|August 4, 2010
[Brachytherapy for the treatment of head and neck cancer]J E Meyer, C Brocks, S Maune, et al.
Nuklearmedizin. Nuclear Medicine|September 12, 2006
High energy probe for detecting lymph node metastases with 18F-FDG in patients with head and neck cancerB Meller, K Sommer, J Gerl, et al.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|September 18, 2013
Assessment of skills using a virtual reality temporal bone surgery simulatorR Linke, A Leichtle, F Sheikh, et al.
Allergy|June 10, 2017
A possible role of stem cells in nasal polyposisL Klimek, M Koennecke, J Mullol, et al.
HNO|July 29, 2005
[Salivary gland carcinomas. 1. Epidemiology, etiology, malignancy criteria, prognostic parameters and classification]S Lang, N Rotter, A Lorenzen, et al.
Pageof 16